Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Letter from Jim Otteson to the ITC Chairman from the ITC

The NDCA case hadn't been adjudicated yet at that point. Claim construction/Markman hearing on its own isn't enough. It's the judgement that would have been binding.

Share
New Message
Please login to post a reply